Intriguingly, an investigation was conducted on the γ-H2AX foci under various cellular conditions, including control, NLRP4 knockdown, NLRP4 overexpression in pancreatic cancer cells, and MitoQ treatment, after olaparib treatment. This evidence concerns the gene NLRP4 and pancreatic neoplasm.